Search

everythinglearnresearchcommunity

for

Search:↓

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

PLD is an effective and safer alternative for treating breast cancer.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Targeting colon cancer stem cells might lead to better treatment results.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.